These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26994682)

  • 1. Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia.
    Samuelson BT; Gernsheimer T; Estey E; Garcia DA
    Thromb Res; 2016 May; 141():104-5. PubMed ID: 26994682
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.
    Houghton DE; Key NS; Zakai NA; Laux JP; Shea TC; Moll S
    Leuk Lymphoma; 2017 Nov; 58(11):2573-2581. PubMed ID: 28393576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A man with acute venous thromboembolism and thrombocytopenia. Heparin induced thrombocytopenia.
    Mohamed M; Hayes R; Mosetlhi T
    BMJ; 2014 Feb; 348():g1164. PubMed ID: 24493671
    [No Abstract]   [Full Text] [Related]  

  • 4. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.
    Khanal N; Bociek RG; Chen B; Vose JM; Armitage JO; Bierman PJ; Maness LJ; Lunning MA; Gundabolu K; Bhatt VR
    Am J Hematol; 2016 Nov; 91(11):E468-E472. PubMed ID: 27489982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.
    Campbell PM; Ippoliti C; Parmar S
    J Oncol Pharm Pract; 2017 Apr; 23(3):220-225. PubMed ID: 26854266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of anticoagulation in the treatment of venous thromboembolism in patients with haematological malignancies and thrombocytopenia: Report of 5 cases and literature review.
    Lim MS; Enjeti AK
    Crit Rev Oncol Hematol; 2016 Sep; 105():92-9. PubMed ID: 27397486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of patients developing thrombocytopenia while receiving anticoagulant therapy for venous thromboembolism.
    Di Micco P; Fontanella A; Falvo N; Bonithon-Kopp C; Decousus H; Riera-Mestre A; Monreal M;
    Int Angiol; 2012 Feb; 31(1):92-5. PubMed ID: 22330631
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.
    Al-Samkari H; Connors JM
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):71-79. PubMed ID: 31808892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes.
    Samuelson Bannow BT; Walter RB; Gernsheimer TB; Garcia DA
    J Thromb Thrombolysis; 2017 Nov; 44(4):442-447. PubMed ID: 28884390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.
    Kopolovic I; Lee AY; Wu C
    Ann Hematol; 2015 Feb; 94(2):329-36. PubMed ID: 25190031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical observation of heparin-induced thrombocytopenia].
    Tian HY; Meng Y; Zhang JB; Ma Q; Cheng GS; Fan FL; Wang J; Wan HM
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1405-7. PubMed ID: 19671335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombosis and DIC in hematological malignancies].
    Asakura H
    Rinsho Ketsueki; 2014 Oct; 55(10):2066-75. PubMed ID: 25297773
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - A case-based review of clinical management.
    Moik F; Makatsariya A; Ay C
    Thromb Res; 2021 Mar; 199():38-42. PubMed ID: 33412483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis.
    Hsu C; Patell R; Zwicker JI
    Blood Adv; 2023 Sep; 7(17):4721-4727. PubMed ID: 36170802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of menorrhagia associated with chemotherapy-induced thrombocytopenia in women with hematologic malignancy.
    Bates JS; Buie LW; Woodis CB
    Pharmacotherapy; 2011 Nov; 31(11):1092-110. PubMed ID: 22026397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis.
    Wang TY; Honeycutt EF; Tapson VF; Moll S; Granger CB; Ohman EM
    Am J Med; 2012 Dec; 125(12):1214-21. PubMed ID: 22939359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy and platelet transfusions in hematologic malignancy patients presenting chemotherapy-induced thrombocytopenia: a French survey.
    Chalayer E; Cavalieri D; Martignoles JA; Genthon A; Tavernier E; Tardy B
    Transfusion; 2017 Jul; 57(7):1717-1723. PubMed ID: 28439927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cohort study investigating compliance with guidelines for platelet count monitoring during heparin thromboprophylaxis.
    Kim S; Trick WE
    Hosp Pract (1995); 2012 Apr; 40(2):88-95. PubMed ID: 22615083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of thrombosis in ambulatory patients with cancer.
    Rana P; Levine MN
    J Clin Oncol; 2009 Oct; 27(29):4885-8. PubMed ID: 19752331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism.
    Stein PD; Hull RD; Matta F; Yaekoub AY; Liang J
    Am J Med; 2009 Oct; 122(10):919-30. PubMed ID: 19682670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.